Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0023890 (
cirrhosis
)
42,195
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
This report shows that loss of heterozygosity at the mannose 6-phosphate/insulin-like growth factor II receptor (
M6P/IGF2R
) locus occurred in 5/8 (63%) dysplastic liver lesions and 11/18 (61%) hepatocellular carcinomas (HCCs) associated with the high risk factors of hepatitis virus infection and
liver cirrhosis
. Mutations in the remaining allele were detected in 6/11 (55%) HCCs, including deletions in a polydeoxyguanosine region known to be a target of microsatellite instability.
M6P/IGF2R
allele loss was also found in cirrhotic tissue of clonal origin adjacent to these dysplastic lesions and HCCs, demonstrating that
M6P/IGF2R
inactivation occurs early in liver carcinogenesis. In conclusion, HCCs frequently develop from clonal expansions of phenotypically normal,
M6P/IGF2R
-mutated hepatocytes, providing further support for the idea that
M6P/IGF2R
functions as a liver tumor-suppressor gene.
...
PMID:Loss of the gene encoding mannose 6-phosphate/insulin-like growth factor II receptor is an early event in liver carcinogenesis. 929 14
Information about
M6P/IGF2R
and p53 genes in hepatocarcinogenesis is limited and controversial. We tested the loss of heterozygosity (LOH) of
M6P/IGF2R
and p53 genes in cirrhotic and neoplastic foci in surgically resected livers of 30 patients with hepatocellular carcinoma (HCC). The DNAs extracted from microdissected specimens were used for polymerase-chain-reaction (PCR)-based assay. LOH of the
M6P/IGF2R
gene in the primary HCCs was detected in 10 of 22 informative cases (45%). In five of these 10 cases (50%), LOH was detected in cirrhotic lesions adjacent to the HCCs. The allelic loss patterns of
M6P/IGF2R
in
liver cirrhosis
(LC) were identical to those in the corresponding HCC, suggesting that HCC could develop from one of the cells in which
M6P/IGF2R
had been lost. Furthermore, LOH of the p53 gene in HCC was detected in 10 (43%) of 23 informative cases, and p53 loss in cirrhotic foci adjacent to HCC was shown in one of the 10 cases (10%). The pattern of allelic loss of the p53 gene in the cirrhotic foci was identical with that in the corresponding tumor. The LOH of the
M6P/IGF2R
and p53 genes occurred independently in HCCs. LOH of the
M6P/IGF2R
locus was a relatively frequent and possibly early event in hepatocarcinogenesis, and LOH of the
M6P/IGF2R
gene and LOH of the p53 gene occurred independently.
...
PMID:Loss of heterozygosity of the mannose 6-phosphate/insulin-like growth factor II receptor and p53 genes in human hepatocellular carcinoma. 1128 87